Prothrombin Time and International Normalized Ratio as Predictors of Factor VII Coagulation Activity in Pediatric

Yotam Bronstein1, Dana Elhadad1, Eyas Midlij1

  • 1Department of Pediatrics, Sanz Medical Center-Laniado Hospital, Netanya, Israel.

Insights

Diagnosing Factor VII (FVII) deficiency requires direct measurement of FVII:C levels, as standard prothrombin time (PT) and international normalized ratio (INR) tests are unreliable predictors in pediatric patients undergoing surgery.

Area of Science:

  • Hematology
  • Pediatric Surgery
  • Coagulation Disorders

Background:

  • Factor VII (FVII) deficiency presents with normal activated partial thromboplastin time (aPTT) and prolonged prothrombin time (PT).
  • Diagnosis relies on Factor VII coagulation activity (FVII:C) measurements, which are costly and time-consuming.
  • Identifying FVII deficiency is crucial for managing bleeding risks, especially before surgical procedures.

Purpose of the Study:

  • To investigate the correlation between PT, INR, and FVII:C in pediatric patients undergoing otolaryngology surgery.
  • To explore alternative, potentially simpler methods for identifying FVII deficiency preoperatively.
  • To assess the predictive accuracy of PT and INR for FVII deficiency in this cohort.

Main Methods:

  • Retrospective analysis of 96 pediatric patients with normal aPTT and prolonged PT undergoing preoperative coagulation workup (2016-2020).
  • Collected FVII:C data alongside PT and INR values.
  • Utilized Spearman correlation and receiver operating characteristic (ROC) curve analysis to evaluate PT and INR as predictors of FVII deficiency.

Main Results:

  • A significant negative correlation was found between FVII:C and both PT and INR.
  • While ROC analysis showed statistically significant results for PT (0.653) and INR (0.669), no optimal cutoff point was identified for high sensitivity and specificity.
  • 67.7% of patients had normal FVII:C, while 32.3% had decreased levels.

Conclusions:

  • Prothrombin time (PT) and international normalized ratio (INR) alone are insufficient to reliably predict clinically relevant Factor VII coagulation activity (FVII:C) levels.
  • Direct measurement of FVII:C is necessary for diagnosing FVII deficiency when PT is abnormal.
  • Accurate FVII:C levels are essential for determining appropriate surgical prophylactic treatment in patients with suspected or confirmed FVII deficiency.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
14